Ipsen S.A. (IPN)
Euronext
Real-time Data
07:00 AM
Day's Range
160.6052 wk Range
109.90Overview - IPN - Ipsen S.A.
Key Statistics
Valuation
Enterprise Value
12.67B
P/E (Trailing)
‪26.84‬
P/E (Forward)
‪11.93‬
PEG Ratio
‪11.93‬
Price / Sales (TTM)
‪3.19‬
Price / Book
‪2.90‬
EV / EBITDA
‪8.72‬
Profitability
Profit Margin
‪11.94%‬
Operating Margin
‪28.48%‬
Return on Assets
‪10.27%‬
Return on Equity
‪11.44%‬
Ownership
Shares Outstanding
82.60M
Float
29.96M
Held by Insiders
‪57.64%‬
Held by Institutions
‪21.27%‬
Price stats
Beta
‪0.32‬
50-Day Avg
‪161.60‬
200-Day Avg
‪150.10‬
Dividends
Payout Ratio
‪25.89%‬
Frequency
Annual
Analyst Consensus
15 analysts
Market Cap - IPN - Ipsen S.A.
Peers - IPN - Ipsen S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Euronext.
- IPNEuronextIpsen S.A.13.49BMarket Cap+29.32%52-week change26.44P/E (Trailing)‪11.94%‬Profit Margin
- FAGREuronextFagron NV1.63BMarket Cap+7.61%52-week change17.88P/E (Trailing)‪8.91%‬Profit Margin
- BOIEuronextBoiron SA453.15MMarket Cap+15.71%52-week change13.83P/E (Trailing)‪6.51%‬Profit Margin
- BONEuronextBonduelle SCA278.01MMarket Cap+5.97%52-week change13.00P/E (Trailing)‪2.27%‬Profit Margin
- EAPIEuronextEuroapi S.A.S.U.93.56MMarket Cap-221.76%52-week change8.84P/E (Trailing)‪-40.80%‬Profit Margin
- ABEuronextAB Science S.A.68.82MMarket Cap-68.86%52-week change-23.77P/E (Trailing)‪-132.62%‬Profit Margin
- PAREuronextParef SA37.88MMarket Cap-48.80%52-week change20.04P/E (Trailing)‪-47.65%‬Profit Margin
Profile Summary - IPN - Ipsen S.A.
About
Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology, rare diseases, and neuroscience. Founded in 1929 by Dr. Henri Beaufour as a family business, it has evolved over…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
